Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Avirulins, a Novel Class of HIV-1 Reverse Transcriptase Inhibitors Effective in the Female Reproductive Tract Mucosa.

Cherne MD, Hall J, Kellner A, Chong CF, Cole AL, Cole AM.

Viruses. 2019 May 1;11(5). pii: E408. doi: 10.3390/v11050408.

2.

Evaluation of the Pig-Tailed Macaque (Macaca nemestrina) as a Model of Human Staphylococcus aureus Nasal Carriage.

Cole AL, Cosgrove Sweeney Y, Lasseter AG, Gray JM, Beavis AC, Chong CF, Hajheidari SV, Beyene A, Patton DL, Cole AM.

Infect Immun. 2018 May 22;86(6). pii: e00043-18. doi: 10.1128/IAI.00043-18. Print 2018 Jun.

3.

Cessation from Smoking Improves Innate Host Defense and Clearance of Experimentally Inoculated Nasal Staphylococcus aureus.

Cole AL, Schmidt-Owens M, Beavis AC, Chong CF, Tarwater PM, Schaus J, Deichen MG, Cole AM.

Infect Immun. 2018 Mar 22;86(4). pii: e00912-17. doi: 10.1128/IAI.00912-17. Print 2018 Apr.

4.

HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.

Cole AM, Cole AL.

Viruses. 2017 May 15;9(5). pii: E108. doi: 10.3390/v9050108. Review.

5.

Synthesis and bioevaluation of substituted chalcones, coumaranones and other flavonoids as anti-HIV agents.

Cole AL, Hossain S, Cole AM, Phanstiel O 4th.

Bioorg Med Chem. 2016 Jun 15;24(12):2768-76. doi: 10.1016/j.bmc.2016.04.045. Epub 2016 Apr 23.

PMID:
27161874
6.

Correction: Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers.

Birse KD, Cole AL, Hirbod T, McKinnon L, Ball TB, Westmacott GR, Kimani J, Plummer F, Cole AM, Burgener A, Broliden K.

PLoS One. 2015 Jul 21;10(7):e0134196. doi: 10.1371/journal.pone.0134196. eCollection 2015. No abstract available.

7.

Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers.

Birse KD, Cole AL, Hirbod T, McKinnon L, Ball TB, Westmacott GR, Kimani J, Plummer F, Cole AM, Burgener A, Broliden K.

PLoS One. 2015 Jun 19;10(6):e0130404. doi: 10.1371/journal.pone.0130404. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0134196.

8.

Morphology-Dependent HIV-Enhancing Effect of Semen-Derived Enhancer of Viral Infection.

Qiao X, Jeon J, Cole AL, Matos JO, Bautista S, Castillo J, Hung I, Gan Z, Tatulian SA, Cole AM, Chen B.

Biophys J. 2015 Apr 21;108(8):2028-37. doi: 10.1016/j.bpj.2015.03.034.

9.
10.

The HIV-1 gp41 ectodomain is cleaved by matriptase to produce a chemotactic peptide that acts through FPR2.

Wood MP, Cole AL, Eade CR, Chen LM, Chai KX, Cole AM.

Immunology. 2014 Jul;142(3):474-83. doi: 10.1111/imm.12278.

11.

A compensatory mutation provides resistance to disparate HIV fusion inhibitor peptides and enhances membrane fusion.

Wood MP, Cole AL, Ruchala P, Waring AJ, Rohan LC, Marx P, Tarwater PM, Gupta P, Cole AM.

PLoS One. 2013;8(2):e55478. doi: 10.1371/journal.pone.0055478. Epub 2013 Feb 5.

12.

The anti-HIV microbicide candidate RC-101 inhibits pathogenic vaginal bacteria without harming endogenous flora or mucosa.

Eade CR, Cole AL, Diaz C, Rohan LC, Parniak MA, Marx P, Tarwater PM, Gupta P, Cole AM.

Am J Reprod Immunol. 2013 Feb;69(2):150-8. doi: 10.1111/aji.12036. Epub 2012 Nov 20.

13.

Identification and characterization of bacterial vaginosis-associated pathogens using a comprehensive cervical-vaginal epithelial coculture assay.

Eade CR, Diaz C, Wood MP, Anastos K, Patterson BK, Gupta P, Cole AL, Cole AM.

PLoS One. 2012;7(11):e50106. doi: 10.1371/journal.pone.0050106. Epub 2012 Nov 15.

14.

HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships.

Levinson P, Choi RY, Cole AL, Hirbod T, Rhedin S, Payne B, Guthrie BL, Bosire R, Cole AM, Farquhar C, Broliden K.

PLoS One. 2012;7(2):e31996. doi: 10.1371/journal.pone.0031996. Epub 2012 Feb 28.

15.

Characterization of the retrocyclin analogue RC-101 as a preventative of Staphylococcus aureus nasal colonization.

Lamers RP, Eade CR, Waring AJ, Cole AL, Cole AM.

Antimicrob Agents Chemother. 2011 Nov;55(11):5338-46. doi: 10.1128/AAC.00619-11. Epub 2011 Aug 8.

16.

Retrocyclins and their activity against HIV-1.

Penberthy WT, Chari S, Cole AL, Cole AM.

Cell Mol Life Sci. 2011 Jul;68(13):2231-42. doi: 10.1007/s00018-011-0715-5. Epub 2011 May 7. Review.

17.

Exoproteome of Staphylococcus aureus reveals putative determinants of nasal carriage.

Muthukrishnan G, Quinn GA, Lamers RP, Diaz C, Cole AL, Chen S, Cole AM.

J Proteome Res. 2011 Apr 1;10(4):2064-78. doi: 10.1021/pr200029r. Epub 2011 Mar 7.

18.

HIV-1 enhancing effect of prostatic acid phosphatase peptides is reduced in human seminal plasma.

Martellini JA, Cole AL, Svoboda P, Stuchlik O, Chen LM, Chai KX, Gangrade BK, Sørensen OE, Pohl J, Cole AM.

PLoS One. 2011 Jan 20;6(1):e16285. doi: 10.1371/journal.pone.0016285.

19.

Grifonin-1: a small HIV-1 entry inhibitor derived from the algal lectin, Griffithsin.

Micewicz ED, Cole AL, Jung CL, Luong H, Phillips ML, Pratikhya P, Sharma S, Waring AJ, Cole AM, Ruchala P.

PLoS One. 2010 Dec 16;5(12):e14360. doi: 10.1371/journal.pone.0014360.

20.

The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques.

Cole AM, Patton DL, Rohan LC, Cole AL, Cosgrove-Sweeney Y, Rogers NA, Ratner D, Sassi AB, Lackman-Smith C, Tarwater P, Ramratnam B, Ruchala P, Lehrer RI, Waring AJ, Gupta P.

PLoS One. 2010 Nov 29;5(11):e15111. doi: 10.1371/journal.pone.0015111.

Supplemental Content

Loading ...
Support Center